Hoon DSB - Search Results

1

Genomic Correlates of Outcome in Tumor-Infiltrating Lymphocyte Therapy for Metastatic Melanoma.

Creasy CA, Meng YJ, Forget MA, Karpinets T, Tomczak K, Stewart C, Torres-Cabala CA, Pilon-Thomas S, Sarnaik AA, Mulé JJ, Garraway L, Bustos M, Zhang J, Patel SP, Diab A, Glitza IC, Yee C, Tawbi H, Wong MK, McQuade J, Hoon DSB, Davies MA, Hwu P, Amaria RN, Haymaker C, Beroukhim R, Bernatchez C. Creasy CA, et al. Among authors: hoon dsb. Clin Cancer Res. 2022 May 2;28(9):1911-1924. doi: 10.1158/1078-0432.CCR-21-1060. Clin Cancer Res. 2022. PMID: 35190823 Free PMC article.

2

Polyvalent melanoma cell vaccine induces delayed-type hypersensitivity and in vitro cellular immune response.

Barth A, Hoon DS, Foshag LJ, Nizze JA, Famatiga E, Okun E, Morton DL. Barth A, et al. Cancer Res. 1994 Jul 1;54(13):3342-5. Cancer Res. 1994. PMID: 8012946

3

A preclinical model to assess the antigenicity of an HLA-A2 melanoma cell vaccine.

Hayashi Y, Hoon DS, Foshag LJ, Park MS, Terasaki PI, Morton DL. Hayashi Y, et al. Cancer. 1993 Aug 1;72(3):750-9. doi: 10.1002/1097-0142(19930801)72:3<750::aid-cncr2820720319>3.0.co;2-v. Cancer. 1993. PMID: 8334627

4

Transfection of interleukin 2 gene into human melanoma cells augments cellular immune response.

Uchiyama A, Hoon DS, Morisaki T, Kaneda Y, Yuzuki DH, Morton DL. Uchiyama A, et al. Cancer Res. 1993 Mar 1;53(5):949-52. Cancer Res. 1993. PMID: 8439968

5

Melanoma-associated antigens as messenger RNA detection markers for melanoma.

Sarantou T, Chi DD, Garrison DA, Conrad AJ, Schmid P, Morton DL, Hoon DS. Sarantou T, et al. Cancer Res. 1997 Apr 1;57(7):1371-6. Cancer Res. 1997. PMID: 9102226

6

Assessment of messenger RNA of beta 1-->4-N-acetylgalactosaminyl-transferase as a molecular marker for metastatic melanoma.

Kuo CT, Bostick PJ, Irie RF, Morton DL, Conrad AJ, Hoon DS. Kuo CT, et al. Clin Cancer Res. 1998 Feb;4(2):411-8. Clin Cancer Res. 1998. PMID: 9516930

7

707-AP peptide recognized by human antibody induces human leukocyte antigen A2-restricted cytotoxic T lymphocyte killing of melanoma.

Takahashi T, Irie RF, Nishinaka Y, Hoon DS. Takahashi T, et al. Clin Cancer Res. 1997 Aug;3(8):1363-70. Clin Cancer Res. 1997. PMID: 9815820

8

Plasma DNA microsatellites as tumor-specific markers and indicators of tumor progression in melanoma patients.

Fujiwara Y, Chi DD, Wang H, Keleman P, Morton DL, Turner R, Hoon DS. Fujiwara Y, et al. Cancer Res. 1999 Apr 1;59(7):1567-71. Cancer Res. 1999. PMID: 10197630

9

Molecular detection of metastatic pancreatic carcinoma cells using a multimarker reverse transcriptase-polymerase chain reaction assay.

Bilchik A, Miyashiro M, Kelley M, Kuo C, Fujiwara Y, Nakamori S, Monden M, Hoon DS. Bilchik A, et al. Cancer. 2000 Mar 1;88(5):1037-44. doi: 10.1002/(sici)1097-0142(20000301)88:5<1037::aid-cncr13>3.0.co;2-h. Cancer. 2000. PMID: 10699892

10

Molecular markers in blood as surrogate prognostic indicators of melanoma recurrence.

Hoon DS, Bostick P, Kuo C, Okamoto T, Wang HJ, Elashoff R, Morton DL. Hoon DS, et al. Cancer Res. 2000 Apr 15;60(8):2253-7. Cancer Res. 2000. PMID: 10786692

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

395 results

Search Page

Filters